A Phase I Trial of Intranasal Moli1901 for Cystic Fibrosis

Medicine & Life Sciences

• Moli1901 100%
• Cystic Fibrosis 43%
• Chlorides 23%
• Nose 13%
• Nasal Mucosa 12%
• Placebos 11%
• Nasal Lavage Fluid 8%
• Fibrosis 8%
• Ringer's Solution 7%
• Chloride Channels 7%
• Amiloride 6%
• Erythema 5%
• Isoproterenol 5%
• L-Lactate Dehydrogenase 5%
• Ulcer 5%
• Albumins 4%
• Drainage 4%
• Pharmaceutical Preparations 4%
• Edema 4%
• Epithelium 4%
• Cell Count 4%
• Healthy Volunteers 3%
• Peptides 3%